Megan Clarke

Source: Wikipedia, the free encyclopedia.
Megan Clarke
Clarke in 2018
Alma materJohns Hopkins Bloomberg School of Public Health
Scientific career
FieldsCancer epidemiology, DNA methylation
InstitutionsNational Institutes of Health
Doctoral advisorCorinne Joshu

Megan A. Clarke is an American

clinical genetics branch at the National Cancer Institute
.

Life

Clarke was a postbaccalaureate fellow in the clinical genetics branch (CGB) at the National Cancer Institute (NCI).[1] She completed a M.H.S. in biochemistry and molecular biology in 2010 and a Ph.D. in epidemiology in 2016, both from the Johns Hopkins Bloomberg School of Public Health.[1] Her dissertation was titled, Early-life exposures and adult cancer risk: a life course approach to cancer prevention.[2] Corinne Joshu was her doctoral advisor.[2] Clarke was a postdoctoral cancer prevention fellow at the CGB.[1]

Clark was promoted to research fellow in 2019 and was appointed as an Earl Stadtman Tenure-Track Investigator in 2020.

next-generation sequencing methylation assay.[1] She leads efforts to validate this assay in natural history studies and has designed a study (Selfie) for large-scale evaluation of methylation testing in self-collected samples.[1]

References

  1. ^ a b c d e f g h "Megan Clarke, Ph.D., M.H.S., biographical sketch and research interests - NCI". dceg.cancer.gov. 2020-10-16. Retrieved 2022-10-17.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ a b Clarke, Megan A. (2015). Early-life exposures and adult cancer risk: a life course approach to cancer prevention (PDF) (Ph.D. thesis). Johns Hopkins Bloomberg School of Public Health.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.